Clinical trial
Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With…
NCT00092209 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00092209 |
|---|---|
| Title | Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302) |
| Official title | A Randomized, Placebo-Controlled, Double-Blind, Parallel Study of the Anti-Hypertensive Efficacy and Safety of Losartan Monotherapy as Compared to HCTZ Monotherapy and to the Combination of Losartan and HCTZ in Japanese Patients With Essential Hypertension |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | MK0954A, hydrochlorothiazide (+) losartan potassium, Comparator: placebo, losartan, hydrochlorothiazide |
| Enrollment | 840 |
| Start date | Apr 1, 2002 |
| Primary completion | Nov 1, 2002 |
| Completion | Nov 1, 2002 |
| First posted | Sep 24, 2004 |
| Last update posted | Feb 15, 2022 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: